Medtronic plc (MDT)
Market Cap | 115.41B |
Revenue (ttm) | 32.32B |
Net Income (ttm) | 4.20B |
Shares Out | 1.33B |
EPS (ttm) | 3.14 |
PE Ratio | 27.76 |
Forward PE | 16.36 |
Dividend | $2.76 (3.17%) |
Ex-Dividend Date | Mar 21, 2024 |
Volume | 8,208,296 |
Open | 84.19 |
Previous Close | 83.70 |
Day's Range | 84.10 - 87.03 |
52-Week Range | 68.84 - 92.02 |
Beta | 0.77 |
Analysts | Buy |
Price Target | 96.00 (+10.13%) |
Earnings Date | May 23, 2024 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2023, Medtronic's revenue was $31.23 billion, a decrease of -1.45% compared to the previous year's $31.69 billion. Earnings were $3.76 billion, a decrease of -25.42%.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for MDT stock is "Buy." The 12-month stock price forecast is $96.0, which is an increase of 10.13% from the latest price.
News
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access DUBLIN , March 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Viz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, Inc., the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic collaboration with Medtronic to improve th...
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Medtronic moves for patent infringement litigation to resume DUBLIN , March 21, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced that the Patent ...
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measures DUBLIN and FLORENCE, Italy , March 9, 2024 /PRNew...
Medtronic announces cash dividend for fourth quarter of fiscal year 2024
Board authorizes $5 billion for share repurchases DUBLIN , March 7, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 7, 2024, approved the company's cash di...
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
DUBLIN , March 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 26th annual Barclays global healthcare conference ...
What's Next For Medtronic Stock After An Upbeat Q3?
Medtronic MDT (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and...
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
DUBLIN , Feb. 29, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced it filed a complaint with the U.S. International Trade Commission (ITC), along ...
Medtronic Nixes Spinoff Plans For Monitoring And Respiratory Units
Medtronic's choice to retain its PMRI Business is mainly driven by the improved performance of its Patient Monitoring segment in recent times, is a result of a comprehensive evaluation of its portfoli...
Medtronic Beats Estimates and Boosts Outlook on Heart, Diabetes Device Sales
Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology firm posted better-than-expected results and raised its guidance on increased demand for its heart and diabetes devices.
Medtronic CEO on earnings: Back to growth in China after challenging few years
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.
Medtronic Stock Jumps. Medical Device Maker Tops Earnings and Raises Forecast.
Medtronic reported adjusted per-share earnings of $1.30, beating Wall Street's call for $1.26, according to FactSet.
Medtronic beats profit estimates on strong demand for heart devices
Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, aided by strong demand for its heart and diabetes devices.
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business re...
Medtronic to announce financial results for its third quarter of fiscal year 2024
DUBLIN , Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 202...
Up Just 6% In 2023 Is Medtronic Stock A Better Pick Over Abbott?
Given its better prospects, we believe Medtronic stock (NYSE: MDT) is a better pick than its peer, Abbott stock (NYSE: ABT). Abbott trades at a higher valuation multiple of 4.9x revenues vs.
Medtronic CEO: The amount of data you have is going to be your currency for innovation
Medtronic CEO Geoffrey Martha, with CNBC's Jim Cramer, joins 'The Exchange' to discuss the impact of weight-loss drugs, AI-driven care, and more.
FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Rechargeable neurostimulator joins the Medtronic Percept ™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN , Jan. 8, 2024 /PRNe...
Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor
With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN , Jan. 8, 2024 /PRNewswire/ -- Medtronic plc (NYS...
Medtronic receives CE Mark for its next generation Micra leadless pacing systems
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN , Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, tod...
Ozempic and other weight-loss drugs' popularity set these stocks up for big gains
Investors have such high hopes for popular weight-loss medications like Wegovy and Ozempic, the wonder drugs have sent shock waves through the stock market.
Final Trade: ETH, BABA, MDT, ET
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
DUBLIN , Dec. 18, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 42nd annual J.P. Morgan healthcare conference on M...
Medtronic gets FDA approval for new heart-condition treatment
Medtronic said the U.S. Food and Drug Administration has approved its PulseSelect Pulsed Field Ablation System for the treatment of two heart conditions.